Active substances
Naproxen + Sumatriptan
- US FDA 5
- Health Canada 2
- US price lines 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TREXIMET | 500MG;EQ 85MG BASE | tablet · oral | AZURITY | Prescription | 15 Apr 2008 |
| SUMATRIPTAN AND NAPROXEN SODIUM | 500MG;EQ 85MG BASE | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 15 Feb 2018 |
| SUMATRIPTAN AND NAPROXEN SODIUM | 500MG;EQ 85MG BASE | tablet · oral | SUN PHARM | Prescription | 20 Jul 2018 |
| SUMATRIPTAN AND NAPROXEN SODIUM | 500MG;EQ 85MG BASE | tablet · oral | RISING | Prescription | 4 Sep 2018 |
| TREXIMET | 60MG;EQ 10MG BASE | tablet · oral | AZURITY | Discontinued | 15 Apr 2008 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP SUMATRIPTAN / NAPROXEN SODIUM | 02566974 | 500 MG; 85 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| SUVEXX | 02496305 | 85 MG; 500 MG | TABLET · ORAL | ARALEZ PHARMACEUTICALS CANADA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | SUMATRIPTAN-NAPROXEN 85-500 MG | $10.46339 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.